EIGR Stock Summary and Trading Ideas (Eiger Biopharmaceuticals | :EIGR)

Eiger BioPharmaceuticals Inc is a commercial stage biopharmaceutical company focused on the development and commercialization of drugs for serious, rare, and ultra-rare diseases with high unmet medical needs and no approved therapies. Its program lonafarnib, a prenylation inhibitor, boosted with ritonavir, for the treatment of Hepatitis Delta Virus (HDV) infection, is in Phase 3 clinical development. Its product candidate pipeline includes Lonafarnib (LNF) in HDV, Peginterferon Lambda (lambda) in HDV, LNF in Progeria, and Progeroid Laminopathies (PL), Avexitide in Post-Bariatric Hypoglycemia (PBH), and Avexitide in Congenital Hyperinsulinism (CHI), all advancing toward Phase 3.

Eiger Biopharmaceuticals trades on the stock market under the symbol EIGR.

As of May 7, 2024, EIGR stock price was flat at $1.73 with million shares trading.

EIGR has a beta of 4.15, meaning it tends to be more sensitive to market movements. EIGR has a correlation of 0.11 to the broad based SPY ETF.

EIGR has a market cap of $2.55 million. This is considered a Sub-Micro Cap stock.

Last quarter Eiger Biopharmaceuticals reported $3 million in Revenue and -$12.30 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$2.70.

In the last 3 years, EIGR stock traded as high as $300.64 and as low as $1.10.

EIGR has underperformed the market in the last year with a price return of -94.9% while the SPY ETF gained +27.0%. EIGR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -73.0% and 0.0%, respectively, while the SPY returned +5.0% and +3.5%, respectively.

EIGR support price is $1.68 and resistance is $1.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EIGR stock will trade within this expected range on the day.